Compile Data Set for Download or QSAR
Report error Found 63 Enz. Inhib. hit(s) with all data for entry = 8533
TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256382BDBM256382(US9487490, 6A)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256393BDBM256393(US9487490, 2B)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256349BDBM256349(US9487490, 2A)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256357BDBM256357(US9487490, 4E)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256366BDBM256366(US9487490, 4N)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256376BDBM256376(US9487490, 4X)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256361BDBM256361(US9487490, 4I)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256375BDBM256375(US9487490, 4W)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256350BDBM256350(US9487490, 2C)
Affinity DataIC50: 4nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256381BDBM256381(US9487490, 5A)
Affinity DataIC50: 4nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256351BDBM256351(US9487490, 2D)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256352BDBM256352(US9487490, 3B)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256383BDBM256383(US9487490, 6C)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256353BDBM256353(US9487490, 4A)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256394BDBM256394(US9487490, 3A)
Affinity DataIC50: 6nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256359BDBM256359(US9487490, 4G)
Affinity DataIC50: 6nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256379BDBM256379(US9487490, 4AA)
Affinity DataIC50: 7nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256346BDBM256346(US9487490, 1J)
Affinity DataIC50: 7nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256380BDBM256380(US9487490, 4AB)
Affinity DataIC50: 8nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256355BDBM256355(US9487490, 4C)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256339BDBM256339(US9487490, 1C)
Affinity DataIC50: 13nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256345BDBM256345(US9487490, 1I)
Affinity DataIC50: 14nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256395BDBM256395(US9487490, 6B)
Affinity DataIC50: 15nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256385BDBM256385(US9487490, 8A)
Affinity DataIC50: 16nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256337BDBM256337(US9487490, 1A)
Affinity DataIC50: 18nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256344BDBM256344(US9487490, 1H)
Affinity DataIC50: 20nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256365BDBM256365(US9487490, 4M)
Affinity DataIC50: 21nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256370BDBM256370(US9487490, 4R)
Affinity DataIC50: 21nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256338BDBM256338(US9487490, 1B)
Affinity DataIC50: 21nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256362BDBM256362(US9487490, 4J)
Affinity DataIC50: 24nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256358BDBM256358(US9487490, 4F)
Affinity DataIC50: 30nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256347BDBM256347(US9487490, 1K)
Affinity DataIC50: 31nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256374BDBM256374(US9487490, 4V)
Affinity DataIC50: 31nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256364BDBM256364(US9487490, 4L)
Affinity DataIC50: 36nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256371BDBM256371(US9487490, 4S)
Affinity DataIC50: 40nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256368BDBM256368(US9487490, 4P)
Affinity DataIC50: 41nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256386BDBM256386(US9487490, 9A)
Affinity DataIC50: 50nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256389BDBM256389(US9487490, 12A)
Affinity DataIC50: 54nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256341BDBM256341(US9487490, 1E)
Affinity DataIC50: 76nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256363BDBM256363(US9487490, 4K)
Affinity DataIC50: 94nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256392BDBM256392(US9487490, 10B)
Affinity DataIC50: 96nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256360BDBM256360(US9487490, 4H)
Affinity DataIC50: 115nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256348BDBM256348(US9487490, 1L)
Affinity DataIC50: 123nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256354BDBM256354(US9487490, 4B)
Affinity DataIC50: 143nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256377BDBM256377(US9487490, 4Y)
Affinity DataIC50: 159nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256373BDBM256373(US9487490, 4U)
Affinity DataIC50: 164nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256342BDBM256342(US9487490, 1F)
Affinity DataIC50: 170nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256356BDBM256356(US9487490, 4D)
Affinity DataIC50: 177nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256343BDBM256343(US9487490, 1G)
Affinity DataIC50: 182nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

TargetIsoform 2 of Nuclear receptor ROR-gamma (RORgT)(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 256391BDBM256391(US9487490, 11A)
Affinity DataIC50: 207nMpH: 7.0 T: 2°CAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2017
Entry Details
US Patent

Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: